| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.064 | 0.09 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.053 | 0.09 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.077 | 0.09 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.056 | 0.09 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.082 | 0.09 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |